RT Journal Article
SR Electronic
T1 Neutrophil extracellular traps and thrombosis in COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.30.20086736
DO 10.1101/2020.04.30.20086736
A1 Zuo, Yu
A1 Zuo, Melanie
A1 Yalavarthi, Srilakshmi
A1 Gockman, Kelsey
A1 Madison, Jacqueline A.
A1 Shi, Hui
A1 Woodward, Wrenn
A1 Lezak, Sean P.
A1 Lugogo, Njira L.
A1 Knight, Jason S.
A1 Kanthi, Yogendra
YR 2020
UL http://medrxiv.org/content/early/2020/05/29/2020.04.30.20086736.abstract
AB Background Early studies of patients with COVID-19 have demonstrated markedly dysregulated coagulation and a high risk of morbid arterial and venous thrombotic events. While elevated levels of blood neutrophils and neutrophil extracellular traps (NETs) have been described in patients with COVID-19, their potential role in COVID-19-associated thrombosis remains unknown.Objectives To elucidate the potential role of hyperactive neutrophils and NET release in COVID-19-associated thrombosis.Patients/Methods This is a retrospective, case-control study of patients hospitalized with COVID-19 who developed thrombosis (n=11), as compared with gender- and age-matched COVID-19 patients without clinical thrombosis (n=33). In addition to capturing clinical data, we measured remnants of NETs (cell-free DNA, myeloperoxidase-DNA complexes, and citrullinated histone H3) and neutrophil-derived S100A8/A9 (calprotectin) in patient sera.Results The majority of patients (9/11) were receiving at least prophylactic doses of heparinoids at the time thrombosis was diagnosed. As compared with controls, patients with COVID-19-associated thrombosis had significantly higher blood levels of markers of NETs (cell-free DNA, myeloperoxidase-DNA complexes, citrullinated histone H3) and neutrophil activation (calprotectin). The thrombosis group also had higher levels of D-dimer, CRP, ferritin, and platelets, but not troponin or neutrophils. Finally, there were strong associations between markers of hyperactive neutrophils (calprotectin and cell-free DNA) and D-dimer.Conclusion Elevated levels of neutrophil activation and NET formation in patients hospitalized with COVID-19 are associated with higher risk of morbid thrombotic complications. These observations underscore the need for urgent investigation into the potential relationship between NETs and unrelenting thrombosis in COVID-19.ESSENTIALSMechanisms contributing to frequent thrombosis in COVID-19 remain unknownNETs and neutrophil activation were measured in patients with COVID-19 -associated thrombosisThrombosis in COVID-19 was associated with higher levels of circulating NETs and calprotectinContributions of neutrophils and NETs to thrombosis in COVID-19 warrant urgent investigationCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThe work was supported by a COVID-19 Cardiovascular Impact Research Ignitor Grant from the Michigan Medicine Frankel Cardiovascular Center as well as by the A. Alfred Taubman Medical Research Institute.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study complied with all relevant ethical regulations, and was approved by the University of Michigan Institutional Review Board (HUM00179409).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesOnce published in a peer-reviewed journal, all primary data will be available upon request to the corresponding authors.